Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/1994
11/24/1994WO1994026775A1 Linear substituted oligoalkyleneimine libraries
11/24/1994WO1994026773A1 Regulation of antigen presentation
11/24/1994WO1994026772A1 Separation of anti-metal chelate antibodies
11/24/1994WO1994026770A1 Electrosynthetic method of modifying biomolecules in particular enzymes
11/24/1994WO1994026295A1 Metal chelates as spacer compounds in biologically active peptides
11/24/1994WO1994026294A1 Ligand precursors for incorporation into peptides
11/24/1994WO1994026287A1 Purification of plasma proteins
11/24/1994CA2162671A1 Separation of anti-metal chelate antibodies
11/24/1994CA2159728A1 Synthetic aglucodalbaheptide antibiotics
11/23/1994EP0625212A1 Methods of detecting alzheimer's disease
11/23/1994EP0625193A1 Insecticidally effective peptides
11/23/1994EP0625161A1 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography
11/23/1994EP0625160A1 Leukinferon preparation
11/23/1994EP0535088A4 Chimeric toxins with improved inter-domain geometry
11/23/1994EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan
11/22/1994US5367072 Reagents for automated synthesis of peptide analogs
11/22/1994US5367063 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
11/22/1994US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994US5367055 Process for treating zein containing material
11/22/1994US5366862 Exposing protein to proteolytic enzymes to degrade; scrambling, binding target, removing, and sequencing
11/22/1994CA1333150C Method for the control of pneumocystis carinii
11/18/1994CA2123921A1 Polypeptide compound and a process for preparation thereof
11/17/1994EP0624165A1 Large, latent complexes of tgf-beta2 and tgf-beta3
11/17/1994EP0624163A1 Cyclic calcitonin derivatives and method for their production
11/17/1994EP0624059A1 Combinatorial strategies for polymer synthesis
11/17/1994EP0109441B1 Human-human hybridomas for neoplasms
11/15/1994US5365456 Method for modelling the electron density of a crystal
11/15/1994US5364851 Internal coupling/cyclization to form helical structures
11/15/1994US5364840 Synthetic calcitonin peptides
11/15/1994US5364837 Follicle stimulating hormone for producing antibodies
11/15/1994US5364762 Major histocompatibility complex (MHC) molecules
11/15/1994US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/15/1994US5364531 Process for affinity purification by immunoadsorption in non-aqueous solvent
11/15/1994CA2123364A1 Process for purification of water soluble penicillin binding protein 2a
11/10/1994WO1994025860A1 Method and system for protein modeling
11/10/1994WO1994025487A1 A method for rapid formation and isolation of focal adhesion complexes
11/10/1994WO1994025482A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
11/10/1994WO1994025481A1 Method of separating glycosylated and non-glycosylated proteins
11/10/1994WO1994025474A1 3-(aminoacyl-amino)-saccharides and method for preparing them
11/10/1994WO1994025432A1 Amino acid amide derivative, agrohorticultural bactericide, and production process
11/10/1994WO1994025071A1 Polyoxime compounds and their preparation
11/10/1994CA2162157A1 Polyoxime compounds and their preparation
11/10/1994CA2161108A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
11/10/1994CA2160703A1 Method of separating glycosylated and non-glycosylated proteins
11/09/1994EP0623680A1 Process to synthesize peptides and its use
11/09/1994EP0623674A1 Interleukin-1 receptors
11/09/1994EP0623628A1 Muscular dystrophy gene products, antibodies thereto and methods for immunodiagnosis of muscular dystrophy
11/09/1994EP0623626A1 Automated allyl deprotection in solid-phase synthesis
11/09/1994EP0623589A1 Coupling reagent and method for coupling amines with carboxylic acids
11/09/1994EP0623352A2 Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumorselective therapy
11/09/1994EP0623216A1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS
11/09/1994EP0623173A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1
11/09/1994EP0623141A1 Selection of binding-molecules
11/09/1994EP0375718B1 Process for the production of aprotinin and aprotinin homologues in yeast
11/09/1994EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins
11/09/1994CN1094618A Process for extracting heme and protein powder from animal blood
11/09/1994CN1026498C Enzymatic membrane method for the synthesis and separation of peptides
11/08/1994US5362903 Diffusion dialysis of solution containing derivative and hydrochloric acid, basification, crystallization
11/08/1994US5362859 Immobilized ligand proteins, chromatography
11/08/1994US5362858 Polyethylene glycol-hirudin conjugates, process for preparing them and their use for the treatment of thromboses
11/08/1994US5362857 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography
11/08/1994US5362855 Imidoester cross-linked hemoglobin compositions
11/08/1994US5362853 Polypeptide derivatives of human granulocyte colony stimulating factor
11/08/1994US5362852 Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
11/08/1994US5362641 Hydrolytic enzymes
11/08/1994US5362447 Automated peptide synthesizer
11/08/1994US5362325 Apparatus for growing crystals in an environment in which opportunity for accessing is limited
11/08/1994CA1332998C Prostate-derived growth factor
11/08/1994CA1332943C Process for preparing perhydrothiazepine derivatives
11/03/1994DE4342132C1 Process for the preparation of virus-inactivated vitamin K-dependent plasma components, and protein C and protein S-containing compositions by membrane chromatography
11/02/1994EP0622458A2 Adrenomedullin
11/02/1994EP0622456A1 Prokaryotic and eukaryotic vectors producing polypeptides containing epitopes of PDGF B
11/02/1994EP0622394A1 Reversible modification of sulfur-containing molecules with polyalkylene glycol derivatives and their use
11/02/1994EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use
11/02/1994EP0621899A1 Expression signal-peptide-free staphylokinases.
11/02/1994EP0621898A1 Chimeric immunogens
11/02/1994EP0621867A1 New endothelin antagonists and their preparation
11/02/1994EP0621788A1 Hemoregulatory peptides
11/02/1994EP0377659B1 Follistatin and method of purifying same
11/02/1994CN1094333A Process for anion-exchange resin containing imidazoline group and its use
11/01/1994US5360928 Synthesis and use of amino acid fluorides as peptide coupling reagents
11/01/1994CA1332819C Separating constituents of a mixture of particles
10/1994
10/27/1994WO1994024314A1 Random chemistry for the generation of new compounds
10/27/1994WO1994024272A1 Process for purifying collagenase
10/27/1994WO1994024157A1 A method of detecting the presence of and converting of a polypeptide
10/27/1994WO1994024088A1 Deallylation reagent and deallylation method using said reagent
10/27/1994WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis
10/27/1994CA2160663A1 A method of detecting the presence of and converting of a polypeptide
10/27/1994CA2160457A1 Random chemistry for the generation of new compounds
10/27/1994CA2160163A1 Deallylation reactive and deallylation process using said reactive
10/26/1994EP0621285A1 Novel megakaryocyte amplifier
10/26/1994EP0620860A1 Preparation of recombinant borrelia proteins
10/26/1994EP0620854A1 Expression and purification of recombinant soluble tissue factor
10/26/1994EP0620824A1 Peptides with tachykinin antagonist activity
10/26/1994EP0431042B1 A method of preparing an active human neutrophil chemotactic factor polypeptide
10/26/1994CN1094093A Progenitor B cell stinulating factor
10/25/1994US5359135 Detection in soil, water, air by preferential affinity to monoclonal antibodies
10/25/1994US5359120 Improvements relating to the production of prodrugs
10/25/1994US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides
10/25/1994US5359030 Coupling of a peptide and polymer; therapy, diagnosis